CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Voluntary Recall: Two Lots of NP Thyroid® Tablets, Due to Sub Potency

Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level.

Doctors Find Drug for Lethal Lung Disease After Decades of Trying

An international team of researchers reports in the New England Journal of Medicine dramatically transforming aPAP treatment by helping develop a drug that patients can inhale once a day so their body will clear out the pulmonary waste.

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

This is not the time to roll out stale messaging delivered by a carousel of health officials trying to convince the public to get the test kits.